Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

519191

registered interest
date	18/05/2016
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Mechanical Thrombectomy
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, how many hospitals in England are equipped to deliver thrombectomy to stroke patients.
tabling member constituency	Sutton and Cheam
tabling member printed	Paul Scully
uin	37148
answer	answer is ministerial correction date of answer 25/05/2016 answer text <p>Information is not collected centrally on the number of hospitals in England which are currently equipped to deliver thrombectomy for stroke.</p><p> </p><p>In February this year, the National Institute for Health and Care Excellence published interventional procedure guidance on mechanical clot retrieval (thrombectomy) for treating acute ischaemic stroke. The guidance sets out that current evidence on the safety and efficacy of this procedure is adequate to support its use, provided that standard arrangements are in place for clinical governance, consent and audit. This guidance does not oblige commissioners to commission thrombectomy nor hospitals to provide it. The guidance is available at:</p><p> </p><p><a href="http://www.nice.org.uk/guidance/ipg548" target="_blank">www.nice.org.uk/guidance/ipg548</a></p><p> </p><p>NHS England is now undertaking work to inform a decision on whether this is a procedure that should be made more widely available.</p> answering member constituency Battersea answering member printed Jane Ellison question first answered 25/05/2016 13:04:41 answering member 3918 label Biography information for Jane Ellison
tabling member	4414 label Biography information for Paul Scully

519192

registered interest
date	18/05/2016
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Strokes: Mental Health Services
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what assessment he has made of the effectiveness and adequacy of mental health support available to stroke survivors.
tabling member constituency	Sutton and Cheam
tabling member printed	Paul Scully
uin	37149
answer	answer is ministerial correction date of answer 25/05/2016 answer text <p>Access to stroke specific psychological support is vital to diagnosing and managing many of the unseen effects of stroke. The Sentinel Stroke National Audit Programme has recently conducted an audit of the provision of services to people with stroke once they have left hospital. The audit found that around 42% of Early Supported Discharge teams and 44% of longer term community rehabilitation teams had some access to psychologists. There are also physiotherapists, nurses and occupational therapists on these teams who often address psychological issues.</p><p> </p><p>We know that there are improvements to be made in providing psychological support for stroke survivors. Clinical commissioning groups are encouraged to consider how the needs of these patients might be met when commissioning services.</p> answering member constituency Battersea answering member printed Jane Ellison question first answered 25/05/2016 14:51:37 answering member 3918 label Biography information for Jane Ellison
tabling member	4414 label Biography information for Paul Scully

226302

registered interest
date	10/03/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Specialised Commissioning Oversight Group
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what the remit is of NHS England's Specialised Commissioning Oversight Group; what plans NHS England has for the future of that Group; and if he will make a statement.
tabling member constituency	Sutton and Cheam
tabling member printed	Paul Burstow
uin	226913
answer	answer is ministerial correction date of answer 17/03/2015 answer text <p>NHS England’s Specialised Commissioning Oversight Group has a remit to:</p><p> </p><p>- provide assurance to NHS England that specialised commissioning strategic priorities are being met through operational delivery;</p><p> </p><p>- drive the continuous improvement of standards and outcomes;</p><p> </p><p>- reduce reduction of variation and inequalities for specialised commissioning; and</p><p> </p><p>- provide assurance that there are robust systems and processes in place for the monitoring and assurance of Specialised Commissioning.</p><p> </p><p> </p><p> </p><p>NHS England has advised that the current plans are to continue the group as established.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 17/03/2015 17:32:01 answering member 3918 label Biography information for Jane Ellison
tabling member	204 label Biography information for Paul Burstow

226303

registered interest
date	10/03/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	National Institute for Health and Care Excellence
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, pursuant to the Answer of 2 March 2015 to Question 224947, for what reasons the data requested is aggregated over the three years 2012-14; and if he will provide the figures for (a) 2012, (b) 2013 and (c) 2014 separately.
tabling member constituency	Sutton and Cheam
tabling member printed	Paul Burstow
uin	226914
answer	answer is ministerial correction date of answer 17/03/2015 answer text <p>I regret that the information in my answer of 2 March 2015 was not provided in the format requested. I apologise for this oversight.</p><p> </p><p> </p><p> </p><p>The information is shown in the table<sup>1</sup>.</p><p> </p><p> </p><p> </p><table><tbody><tr><td><p> </p></td><td><p>2012</p></td><td><p>2013</p></td><td><p>2014</p></td></tr><tr><td><p>Patient organisations</p></td><td><p>46</p></td><td><p>39</p></td><td><p>40</p></td></tr><tr><td><p>Manufacturers</p></td><td><p>18</p></td><td><p>22</p></td><td><p>32</p></td></tr><tr><td><p>Professional organisations</p></td><td><p>58</p></td><td><p>47</p></td><td><p>49</p></td></tr><tr><td><p>Other organisations</p></td><td><p>23</p></td><td><p>12</p></td><td><p>13</p></td></tr></tbody></table><p> </p><p><sup>1</sup> Some organisations will be involved in more than one year.</p><p> </p><p> </p><p> </p><p><em>Source:</em> National Institute for Health and Care Excellence</p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 17/03/2015 17:30:50 answering member 4020 label Biography information for George Freeman
tabling member	204 label Biography information for Paul Burstow

226311

registered interest
date	10/03/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	NHS: Finance
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, pursuant to the Answer of 2 March 2015 to Question 224949, on what date NHS England began reviewing its policy on individual funding requests; which parties are contributing to that review; when he expects the review to conclude; and if he will make a statement.
tabling member constituency	Sutton and Cheam
tabling member printed	Paul Burstow
uin	227004
answer	answer is ministerial correction date of answer 17/03/2015 answer text <p>NHS England has advised that it will be reviewing its policy on individual funding requests during 2015 and the timescale of this review will be determined in the coming weeks.</p><p> </p><p> </p><p> </p><p>NHS England will consider how the policy will be reviewed and who will be involved.</p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 17/03/2015 17:08:30 answering member 4020 label Biography information for George Freeman
tabling member	204 label Biography information for Paul Burstow

226318

registered interest
date	10/03/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Co-careldopa
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, pursuant to the Answer of 2 March 2015 to Question 224941, what the precise recommendation made by the Clinical Reference Group referred to in that Answer was; whether that recommendation related to (a) in year or (b) ongoing routine commissioning; and if he will make a statement.
tabling member constituency	Sutton and Cheam
tabling member printed	Paul Burstow
uin	227005
answer	answer is ministerial correction date of answer 17/03/2015 answer text <p>NHS England has advised that its Neuroscience Clinical Reference Group’s recommendation was to approve the clinical policy to support the routine commissioning of levodopa-carpidopa intestinal gel for advanced Parkinson’s disease and to go out to full public consultation.</p><p> </p><p> </p><p> </p><p>The recommendation related to an in year commissioning decision.</p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 17/03/2015 15:53:34 answering member 4020 label Biography information for George Freeman
tabling member	204 label Biography information for Paul Burstow

222990

registered interest
date	23/02/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	NHS: Finance
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, whether the specialised services circular issued by NHS England on 30 September 2013, ID SSC1315, on Individual Funding Requests for Clinically Urgent Treatment Outside Established Policy, remains in force; whether individual requests for treatments for which a cohort policy is in development will not be funded without evidence of clinical exceptionality; how many individual funding requests for (a) all treatment and (b) Duodopa were (i) approved and (ii) not approved under the (A) critical clinically urgent criteria and (B) urgent non-clinical criteria in each month in which that circular has been in force; if all requests made under the urgent non-clinical criteria received expert opinion from the Chair of the relevant clinical reference group within two weeks; and if he will make a statement.
tabling member constituency	Sutton and Cheam
tabling member printed	Paul Burstow
uin	224981
answer	answer is ministerial correction date of answer 02/03/2015 answer text <p>NHS England has confirmed that, to be successful, any individual funding request (IFR) for Duodopa must demonstrate exceptionality against the cohort of patients with Parkinson's disease in NHS England’s draft commissioning policy.</p><p> </p><p> </p><p> </p><p>Although it does not routinely commission Duodopa for the treatment of advanced Parkinson’s disease, NHS England has advised that, it will consider funding this treatment in exceptional clinical circumstances. Clinicians can submit IFRs for this treatment to NHS England on behalf of their patients.</p><p> </p><p> </p><p> </p><p>NHS England has IFRs for all treatments/interventions were received by NHS England through the standard IFR process. 238 of these were considered by an NHS England IFR panel.</p><p> </p><p> </p><p> </p><p>21 requests for Duodopa were received as shown in the table.</p><p> </p><p> </p><p> </p><table><tbody><tr><td><p>IFR team</p></td><td><p>Indication</p></td><td><p>Number of IFRs received</p></td><td><p>Approved</p></td><td><p>Not Approved</p></td></tr><tr><td><p>Midlands and East</p></td><td><p>Duodopa</p></td><td><p>3</p></td><td><p>0</p></td><td><p>3</p></td></tr><tr><td><p>North</p></td><td><p>Duodopa</p></td><td><p>5</p></td><td><p>0</p></td><td><p>5</p></td></tr><tr><td><p>London</p></td><td><p>Duodopa</p></td><td><p>11</p></td><td><p>0</p></td><td><p>11</p></td></tr><tr><td><p>South</p></td><td><p>Duodopa</p></td><td><p>2</p></td><td><p>0</p></td><td><p>2</p></td></tr></tbody></table><p> </p><p><em>Source:</em> NHS England</p><p> </p><p><strong> </strong></p><p> </p><p>NHS England is unable to provide monthly figures due to the small volume of requests as this could lead to the identification of individual patients.</p><p> </p><p> </p><p> </p><p>NHS England has advised that the SSC1315 on Individual Funding Requests for Clinically Urgent Treatment Outside Established Policy has officially expired but has been maintained whilst a review is taking place regarding how such cases will be handled in the future.</p><p> </p><p> </p><p> </p><p>It has confirmed that not all non-clinical IFRs require an expert opinion. This is only sought when it is felt that further expert opinion is required. It should be noted that Duodopa became NHS England’s responsibility from April 2014. Prior to then cases were considered by clinical commissioning groups.</p><p> </p><p> </p><p> </p><p>Details of IFRs processed under specialised services circular SSC1315 for the period 1 October 2013 to 24 February 2015 are shown in the table:</p><p> </p><p><strong> </strong></p><p> </p><table><tbody><tr><td rowspan="2"><p>IFR team</p></td><td rowspan="2"><p>Indication</p></td><td rowspan="2"><p>Number of IFRs received</p></td><td colspan="2"><p>Approved</p></td><td colspan="2"><p>Not Approved</p></td></tr><tr><td><p>critical clinically urgent</p></td><td><p>urgent non-clinical</p></td><td><p>critical clinically urgent</p></td><td><p>urgent non-clinical</p></td></tr><tr><td rowspan="2"><p>Midlands &amp; East</p></td><td><p>All</p></td><td><p>11</p></td><td><p>5</p></td><td><p>6</p></td><td><p>0</p></td><td><p>0</p></td></tr><tr><td><p>Duodopa</p></td><td><p>0</p></td><td><p>0</p></td><td><p>0</p></td><td><p>0</p></td><td><p>0</p></td></tr><tr><td rowspan="2"><p>North</p></td><td><p>All</p></td><td><p>13</p></td><td><p>12</p></td><td><p>0</p></td><td><p>1</p></td><td><p>0</p></td></tr><tr><td><p>Duodopa</p></td><td><p>0</p></td><td><p>0</p></td><td><p>0</p></td><td><p>0</p></td><td><p>0</p></td></tr><tr><td rowspan="2"><p>London</p></td><td><p>All</p></td><td><p>37</p></td><td><p>31</p></td><td><p>3</p></td><td><p>3</p></td><td><p>0</p></td></tr><tr><td><p>Duodopa</p></td><td><p>0</p></td><td><p>0</p></td><td><p>0</p></td><td><p>0</p></td><td><p>0</p></td></tr><tr><td rowspan="2"><p>South</p></td><td><p>All</p></td><td><p>18</p></td><td><p>10</p></td><td><p>1</p></td><td><p>3</p></td><td><p>4</p></td></tr><tr><td><p>Duodopa</p></td><td><p>6</p></td><td><p>0</p></td><td><p>0</p></td><td><p>0</p></td><td><p>0</p></td></tr></tbody></table><p> </p><p><em>Source:</em> NHS England</p><p> </p><p> </p><p> </p><p>Further information about NHS England’s IFR process is available at:</p><p> </p><p> </p><p> </p><p><a href="http://www.england.nhs.uk/wp-content/uploads/2013/04/cp-03.pdf" target="_blank">www.england.nhs.uk/wp-content/uploads/2013/04/cp-03.pdf</a></p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman grouped question UIN 224942 224946 question first answered 02/03/2015 17:40:04 answering member 4020 label Biography information for George Freeman
tabling member	204 label Biography information for Paul Burstow

222997

registered interest
date	23/02/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Clinical Priorities Advisory Group
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, whether NHS England is continuing to consider whether to publish the minutes of meetings of the Clinical Priorities Advisory Group; what factors it is taking into consideration before making that decision; and if he will make a statement.
tabling member constituency	Sutton and Cheam
tabling member printed	Paul Burstow
uin	224943
answer	answer is ministerial correction date of answer 02/03/2015 answer text <p>NHS England has advised that it is planning to publish the Clinical Priorities Advisory Group (CPAG) minutes for the meeting which took place in February. It plans to publish these minutes and others following the current NHS England consultation on the principles underpinning prioritisation in specialised services. The consultation closes on 27 April 2015 and can be found at:</p><p> </p><p> </p><p> </p><p><a href="http://www.engage.england.nhs.uk/consultation/investing-in-specialised-commissioning" target="_blank">www.engage.england.nhs.uk/consultation/investing-in-specialised-commissioning</a></p><p> </p><p> </p><p> </p><p>NHS England has advised that it intends to routinely publish minutes of CPAG meetings in the future, and is considering how to make available minutes of previous meetings.</p><p> </p><p><strong> </strong></p><p> </p><p><strong> </strong></p><p> </p><p><strong> </strong></p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 02/03/2015 17:42:49 answering member 3918 label Biography information for Jane Ellison
tabling member	204 label Biography information for Paul Burstow

223001

registered interest
date	23/02/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Co-careldopa
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, on what basis NHS England's Clinical Priorities Advisory Group has recommended that Duodopa should not be routinely commissioned by NHS England; what factors NHS England's Clinical Priorities Advisory Group took into consideration in reaching that recommendation; what advice NHS England's Clinical Priorities Advisory Group sought from patient representatives in reaching that decision; what process NHS England follows to allow interested parties to appeal recommendations by the Clinical Priorities Advisory Group; and if he will make a statement.
tabling member constituency	Sutton and Cheam
tabling member printed	Paul Burstow
uin	224941
answer	answer is ministerial correction date of answer 02/03/2015 answer text <p>NHS England has advised that its Neuroscience Clinical Reference Group (CRG) carefully reviewed the clinical evidence for the treatment of advanced Parkinson’s disease with Duodopa (co-careldopa) and made a recommendation to the Clinical Priorities Advisory Group (CPAG).</p><p> </p><p> </p><p> </p><p>CPAG accepted the CRG’s recommendation that Duodopa should not be routinely commissioned for treatment of this condition and, in turn, made this recommendation to the Directly Commissioned Services Committee of the NHS England Board. The Board committee endorsed the recommendation in June 2014.</p><p> </p><p> </p><p> </p><p>Both patients and carers were involved in the decision-making process. There are four patient /carer representatives on the CRG, and patient and public stakeholders registered with the CRG were given an opportunity to feed in their views before the Group made its recommendations to CPAG. CPAG’s membership includes a lay chair and four patient representatives.</p><p> </p><p> </p><p> </p><p>Further work has been undertaken on Duodopa since NHS England’s Board endorsed CPAG’s decision in June 2014 and NHS England will reconsider whether or not to commission this treatment, alongside a number of other specialised treatments, later this year.</p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 02/03/2015 17:47:01 answering member 4020 label Biography information for George Freeman
tabling member	204 label Biography information for Paul Burstow

223004

registered interest
date	23/02/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	NHS: Finance
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, if he will request that NHS England review its policy on individual funding requests.
tabling member constituency	Sutton and Cheam
tabling member printed	Paul Burstow
uin	224949
answer	answer is ministerial correction date of answer 02/03/2015 answer text <p>We have no such plans. We understand that NHS England is currently reviewing its generic policies, including its interim commissioning policy on individual funding requests.</p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 02/03/2015 17:45:14 answering member 4020 label Biography information for George Freeman
tabling member	204 label Biography information for Paul Burstow